Abstract: A substance delivery module (4) and apparatus (2) for delivering a substance in aerosol form are disclosed. The substance delivery module (4) comprises a substance container (90), a piston (62) and an actuator (100) configured to engage the substance container (90) and urge the substance container (90) onto the piston (62), so dispensing the substance into the through passage (102) of the piston. The actuator (100) and substance container (90) are mounted in the substance delivery module (4) for relative motion, such relative motion bringing the actuator (100) into engagement with the substance container (90). The substance delivery module (4) may be assembled with an aerosol generator (10) and an aerosol delivery conduit (14) to form an apparatus (2) for delivering a substance in aerosol form. The apparatus (2) may further comprise a control module (6).

Abstract: A substance delivery module and apparatus for delivering substance in aerosol form are disclosed. The substance delivery module includes a plurality of substance containers and a plurality of pistons, with each substance container being mounted in the module for cooperation with a dedicated piston. Another substance delivery module is disclosed that includes a piston defining a delivery axis and a substance container, moveably mounted with respect to the piston. The substance container is moveable along the delivery axis and may, for example, be moved toward and onto the piston. Either of the substance delivery modules may be assembled with an aerosol generator and an aerosol delivery conduit in fluid communication with the aerosol generator to form an apparatus for delivering substance in aerosol form. The apparatus may further include a control module.

Abstract: Therapy regimes of a plurality of subjects are remotely monitored and/or managed, wherein the therapy regimes include reception of aerosolized medicament. This enables users such as medical care providers, researchers, clinic administrators, and/or other users to monitor and/or manage the therapy regimes of the plurality of subjects through a centralized access point. This reduces physical requirements of proximity for the users and/or the subjects, alleviates the administrative burden placed on the users to manage and/or monitor individual therapy regimes, and/or provides other enhancements over convention systems.

Abstract: There is provided a method of monitoring the lung function of a patient, the method comprising determining one or both of an inhalation time and a rest time for a patient that is using a respiratory apparatus, the one or both of an inhalation time and a rest time for the patient being determined from measurements obtained from the respiratory apparatus, wherein the inhalation time is the amount of time for which the patient inhales through the respiratory apparatus, and the rest time is the amount of time between the end of an exhalation and the start of the next inhalation; and analyzing the determined one or both of the inhalation time and rest time to determine an indication of the lung function of the patient.

Abstract: Therapy regimes of a plurality of subjects are remotely monitored and/or managed, wherein the therapy regimes include reception of aerosolized medicament. This enables users such as medical care providers, researchers, clinic administrators, and/or other users to monitor and/or manage the therapy regimes of the plurality of subjects through a centralized access point. This reduces physical requirements of proximity for the users and/or the subjects, alleviates the administrative the burden placed on the users to manage and/or monitor individual therapy regimes, and/or provides other enhancements over convention systems.

Abstract: A monitoring device includes a housing that is constructed and arranged to be removably attached to a drug delivery device for an inhaled drug. A color detector is operatively associated with the housing and constructed and arranged to detect an identifying color of at least a portion of the drug delivery device when the housing is attached to the drug delivery device and to output color information for use by a processor to, based on the detected color, identify information about the inhaled drug.

Abstract: A nebulizer comprises a head detachably coupled to a body. The head comprises a nebulizer, an air channel and a flow sensor. A nebulized liquid is released in an air channel that ends in a mouth piece through which a user inhales and exhales. The inhaling and exhaling causes a flow in the air channel which is detected with the flow sensor. The nebulizer is controlled by a controller included in the body.

Abstract: A nebulizer (1) comprises one or more removable components (5,7,9,13), for example a mesh assembly (9), mouthpiece, plunger assembly (7) and medication chamber (13), each having an associated data carrier (5a, 7a, 9a). The data carrier (5a, 7a, 9a) can be used to store information indicating the type of removable component (5,7,9,13) that is fitted to the nebulizer (1). A removable component (5,7,9,13) may be from a set of such removable components. For example, a mouthpiece (5) fitted to the nebulizer (1) may be from a set of mouthpieces having different flow rates. The data carrier (5a, 7a, 9a) may also be used to control operation of the nebulizer (1). A data carrier (9a) attached to a mesh (9) may be used to prevent the nebulizer (1) from being used when the mesh (9) has been used a predetermined number of times.

Abstract: There is provided a method of determining whether a first type of liquid is being used in a nebulizer, the method comprising obtaining a measurement of the time taken by the nebulizer to nebulize a specified volume of liquid that was held therein, comparing the time taken to nebulize the specified volume of liquid to an estimated value for the time required to nebulize the same volume of the first type of liquid, and determining whether the liquid nebulized by the nebulizer was the first type of liquid based on the comparison.

Abstract: A substance delivery module (4) and apparatus (2) for delivering a substance in aerosol form are disclosed. The substance delivery module (4) comprises a substance container (90), a piston (62) and an actuator (100) configured to engage the substance container (90) and urge the substance container (90) onto the piston (62), so dispensing the substance into the through passage (102) of the piston. The actuator (100) and substance container (90) are mounted in the substance delivery module (4) for relative motion, such relative motion bringing the actuator (100) into engagement with the substance container (90). The substance delivery module (4) may be assembled with an aerosol generator (10) and an aerosol delivery conduit (14) to form an apparatus (2) for delivering a substance in aerosol form. The apparatus (2) may further comprise a control module (6).

Abstract: A substance delivery module (4) and apparatus (2) for delivering substance in aerosol form are disclosed. The substance delivery module (4) comprises a plurality of substance containers (90) and a plurality of pistons (76), with each substance container (90) being mounted in the module for cooperation with a dedicated piston (76). Another substance delivery module (4) is disclosed comprising a piston (76) defining a delivery axis (150) and a substance container (90), moveably mounted with respect to the piston (76). The substance container (90) is moveable along the delivery axis (150) and may for example be moved towards and onto the piston (76). Either of the substance delivery modules (4) may be assembled with an aerosol generator (10) and an aerosol delivery conduit (14) in fluid communication with the aerosol generator (10) to form an apparatus (2) for delivering substance in aerosol form. The apparatus (2) may further comprise a control module (6).

Abstract: A nebulizer comprises a head detachably coupled to a body. The head comprises nebulizing means, an air channel and a flow sensor. A nebulized liquid is released in an air channel that ends in a mouth piece through which a user inhales and exhales. The inhaling and exhaling causes a flow in the air channel which is detected with the flow sensor. The nebulizing means are controlled by control means included in the body.

Abstract: A server is configured to be communicatively linked with drug delivery devices used by a plurality of different subjects to receive aerosolized medicament as part of a therapy regime. The server provides a user with a user interface that enables the user to access therapy information related to the therapy of a plurality of different subjects. This may facilitate the monitoring of therapy received by the plurality of subjects.

Abstract: A medication delivery apparatus (5) includes a reservoir for holding a liquid medication and a metering device (25) coupled to the reservoir for supplying a dose of the liquid medication to the reservoir. The metering device includes an upper chamber, a lower chamber coupled to the upper chamber, a piston selectively moveable within the upper chamber and the lower chamber and a valve providing selective fluid communication between the lower chamber and the reservoir in response to movement of the piston.

Abstract: There is provided a method of monitoring the lung function of a patient, the method comprising determining one or both of an inhalation time and a rest time for a patient that is using a respiratory apparatus, the one or both of an inhalation time and a rest time for the patient being determined from measurements obtained from the respiratory apparatus, wherein the inhalation time is the amount of time for which the patient inhales through the respiratory apparatus, and the rest time is the amount of time between the end of an exhalation and the start of the next inhalation; and analyzing the determined one or both of the inhalation time and rest time to determine an indication of the lung function of the patient.

Abstract: A drug package comprising a plurality of drug vials containing drugs for delivery to a patient in a drug delivery device; and a data carrier including drug treatment information for use by the drug delivery apparatus.

Abstract: There is provided a method of determining whether a first type of liquid is being used in a nebulizer, the method comprising obtaining a measurement of the time taken by the nebulizer to nebulize a specified volume of liquid that was held therein, comparing the time taken to nebulize the specified volume of liquid to an estimated value for the time required to nebulize the same volume of the first type of liquid, and determining whether the liquid nebulized by the nebulizer was the first type of liquid based on the comparison.

Abstract: Therapy regimes of a plurality of subjects are remotely monitored and/or managed, wherein the therapy regimes include reception of aerosolized medicament. This enables users such as medical care providers, researchers, clinic administrators, and/or other users to monitor and/or manage the therapy regimes of the plurality of subjects through a centralized access point. This reduces physical requirements of proximity for the users and/or the subjects, alleviates the administrative burden placed on the users to manage and/or monitor individual therapy regimes, and/or provides other enhancements over convention systems.

Abstract: A nebulizer includes nebulization device for nebulizing a substance and a reservoir having a metering chamber arranged so as to feed a substance to be nebulized to the nebulization device and a second chamber arranged to hold and retain any of this substance in excess of the volume held in the metering chamber.

Abstract: A drug delivery apparatus of the type which releases a drug in aerosolized form into the inhaled airstream of a person, programmed to release the drug in a pulse which ends a pre-set time before the person is expected to stop inhaling. In doing so, a minimum residence time within the lungs is created, and drug treatment time can be reduced. A corresponding method of controlling a drug delivery apparatus comprises the step of controlling the apparatus to release the drug in aerosolized form into the inhaled airstream of a person in a pulse which ends a pre-set time before the person is expected to stop inhaling.